Quinolinone derivatives

Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug selected from 5-FU or CPT 11 and a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of...

Full description

Saved in:
Bibliographic Details
Main Authors PECCHI Sabina, MACHAJEWSKI Timothy D, McCREA William R, RENHOWE Paul A, McBRIDE Christopher, SHAFER Cynthia M, TAYLOR Clarke, JAZAN Elisa, HEISE Carla
Format Patent
LanguageEnglish
Published 09.12.2009
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Organic compounds having the formulas (I) and (II) are provided where the variables have the values described herein. Medicaments include an anti-cancer drug selected from 5-FU or CPT 11 and a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treatin along with an anti-cancer drug selected from 5-FU or CPT-11. The medicaments may be used in treating cancer. The use of a compound of formula (I) or formula (II), a tautomer of the compound, a pharmaceutically acceptable salt of the compound, or a pharmaceutically acceptable salt of the tautomer in treating cancer in conjunction with an anti-cancer drug selected from 5-FU or CPT-11 is also provided.
Bibliography:Application Number: AP20040003166